Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
Diver S, Haldar K, McDowell PJ, Busby J, Mistry V, Micieli C, Brown V, Cox C, Yang F, Borg C, Shrimanker R, Ramsheh MY, Hardman T, Arron J, Bradding P, Cowan D, Mansur AH, Fowler SJ, Lordan J, Menzies-Gow A, Robinson D, Matthews J, Pavord ID, Chaudhuri R, Heaney LG, Barer MR, Brightling C; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). Diver S, et al. Among authors: shrimanker r. Allergy. 2022 Nov;77(11):3362-3376. doi: 10.1111/all.15425. Epub 2022 Jul 15. Allergy. 2022. PMID: 35778780 Free article.
Emerging Biologics in Severe Asthma.
Pavord ID, Hilvering B, Shrimanker R. Pavord ID, et al. Among authors: shrimanker r. Immunol Allergy Clin North Am. 2016 Aug;36(3):609-23. doi: 10.1016/j.iac.2016.04.001. Immunol Allergy Clin North Am. 2016. PMID: 27401629 Review.
Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma.
Hilvering B, Hinks TSC, Stöger L, Marchi E, Salimi M, Shrimanker R, Liu W, Chen W, Luo J, Go S, Powell T, Cane J, Thulborn S, Kurioka A, Leng T, Matthews J, Connolly C, Borg C, Bafadhel M, Willberg CB, Ramasamy A, Djukanović R, Ogg G, Pavord ID, Klenerman P, Xue L. Hilvering B, et al. Among authors: shrimanker r. Mucosal Immunol. 2018 Sep;11(5):1408-1419. doi: 10.1038/s41385-018-0049-9. Epub 2018 Jun 15. Mucosal Immunol. 2018. PMID: 29907870 Free PMC article.
Exacerbations of severe asthma in patients treated with mepolizumab.
Shrimanker R, Pavord ID, Yancey S, Heaney LG, Green RH, Bradding P, Hargadon B, Brightling CE, Wardlaw AJ, Haldar P. Shrimanker R, et al. Eur Respir J. 2018 Dec 13;52(6):1801127. doi: 10.1183/13993003.01127-2018. Print 2018 Dec. Eur Respir J. 2018. PMID: 30464012 Free article. Clinical Trial. No abstract available.
Correction: Synergistic activation of pro-inflammatory type-2 CD8 + T lymphocytes by lipid mediators in severe eosinophilic asthma.
Hilvering B, Hinks TSC, Stöger L, Marchi E, Salimi M, Shrimanker R, Liu W, Chen W, Luo J, Go S, Powell T, Cane J, Thulborn S, Kurioka A, Leng T, Matthews J, Connolly C, Borg C, Bafadhel M, Willberg CB, Ramasamy A, Djukanović R, Ogg G, Pavord ID, Klenerman P, Xue L. Hilvering B, et al. Among authors: shrimanker r. Mucosal Immunol. 2019 Mar;12(2):581. doi: 10.1038/s41385-018-0121-5. Mucosal Immunol. 2019. PMID: 30518781 Free PMC article.
Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.
Luo J, Wu Y, Shrimanker R, Go S, Ye Y, Hardman C, Nahler J, Chen YL, Stöger L, Zeng N, Liu W, Reed L, Tolkovsky AM, Klenerman P, Ogg G, Pavord ID, Xue L. Luo J, et al. Among authors: shrimanker r. J Allergy Clin Immunol. 2019 Dec;144(6):1722-1726.e10. doi: 10.1016/j.jaci.2019.08.008. Epub 2019 Aug 22. J Allergy Clin Immunol. 2019. PMID: 31445099 No abstract available.
29 results